Influenza Virus-like Particle Containing Two Different Subtypes of Hemagglutinin Confers Protection in Mice Against Lethal Challenge With A/PR8 (H1N1) and A/HK (H3N2) Viruses

CITEDBY Reports

  1. Zhu Yang, Zenglin Pei, Kejia Jiang, Wenqing Yu, Yu Wang, . Detection and Molecular Characterization of the Avian Influenza A (H7N9) Virus in Eastern China in 2013. Jundishapur Journal of Microbiology, 2016; 9(12): .
    Crossref
  2. Fu-Shi Quan, Young-Tae Lee, Ki-Hye Kim, Min-Chul Kim, Sang-Moo Kang, . Progress in developing virus-like particle influenza vaccines. Expert Review of Vaccines, 2016; 15(10): 1281.
    Crossref
  3. Nima Mirzaei, Rakhshandeh Nategh, Hoorieh Soleimanjahi, Nour Amirmozafari, Farhad Rezaei, Talat Mokhtari Azad, . Construction of Recombinant Bacmid Containing M2e-Ctxb and Producing the Fusion Protein in Insect Cell Lines. Iranian Red Crescent Medical Journal, 2014; 16(2): .
    Crossref
  4. Zhiguang Ren, Xianliang Ji, Lingnan Meng, Yurong Wei, Tiecheng Wang, Na Feng, Xuexing Zheng, Hualei Wang, Nan Li, Xiaolong Gao, Hongli Jin, Yongkun Zhao, Songtao Yang, Chuan Qin, Yuwei Gao, Xianzhu Xia, . H5N1 influenza virus-like particle vaccine protects mice from heterologous virus challenge better than whole inactivated virus. Virus Research, 2015; 200(): 9.
    Crossref
  5. Asghar Abdoli, Hoorieh Soleimanjahi, Masoumeh Tavassoti Kheiri, Abbas Jamali, Vahideh Mazaheri, Meghdad Abdollahpour Alitappeh, . An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice. Pathogens and Disease, 2014; (): n/a.
    Crossref